Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trial
FOCUS
April 15, 2024
Trial Site Technical Support
The PREGART project principal investigators (PIs) and PhD students’ supervisors, Professor Eleni Aklilu and Professor Eyasu Makonnen, paid a visit to…
April 15, 2024
Amended Protocol Popularization Workshop
The PREGART clinical trial project conducted an amended protocol popularization workshop from March 15–16, 2024. The PREGART Project Office in…
June 14, 2023
Clinical Trial Methodology and Interpretation – Ethiopia
The Pregart clinical trial project conducted training on Clinical Trial Methodologies for trial staff working at study hospitals from March 20-22,…
March 9, 2023
Capacity building: PhD and postdoctoral careers in the Pregart clinical trial
Hawassa University PREGART clinical trial project PhD candidates presented their individual study plan (ISP) to the postgraduate admission committee…
January 5, 2023
PREGART clinical trial in Ethiopia achieved 25% of the participant’s recruitment
The PREGART Clinical trial in Ethiopia has been enrolling participants since May 2021. The participant recruitment was initiated after 18 months of…
January 5, 2023
Ethiopia Food and Regulatory Authority (EFDA) conducted a GCP inspection on the PREGART clinical trial implementation
The Ethiopia Food and Regulatory Authority (EFDA) pharmacovigilance and clinical trial authorization unit conducted an inspection of the PREGART…
PREGART video presentation
DOCUMENTS
Short facts
PREGART brief description
Impact
Impact of PREGART project
The project
Full description of PREGART project
Work packages
Work packages of PREGART project